Negma Group

Elevate Pay is a financial technology company that specializes in providing digital banking services and products. The company has developed a digital banking application that allows users to open bank accounts online and access fee-free accounts in both local currency and US dollars. Additionally, Elevate Pay offers free remittance services, enabling users to receive international transfers from various countries without incurring fees. The company also issues a free USD Mastercard, facilitating seamless transactions. Through these offerings, Elevate Pay aims to deliver regulated banking services that are innovative, fair, and accessible, ultimately enhancing the financial well-being of its consumers.

Theneo is a developer of AI-driven software that specializes in creating high-quality and interactive API documentation. The company's innovative tool automates the content writing process for application programming interfaces, significantly reducing the workload for development teams. This automation allows both developers and non-technical team members to enhance productivity and maintain standardized documentation efficiently. Theneo's solution is designed to streamline the documentation process, making it accessible and cost-effective for businesses looking to improve their API documentation practices.

Evaxion Biotech A/S is a clinical-stage biotechnology company focused on leveraging artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer and infectious diseases. Utilizing its proprietary AI-immunology technology, the company is advancing a diverse pipeline of product candidates, which includes three patient-specific cancer immunotherapies, two of which are currently in Phase I/IIa clinical development. In addition to its cancer therapies, Evaxion is also working on a portfolio of vaccines aimed at preventing bacterial and viral infections, with one program in preclinical development targeting Methicillin-resistant Staphylococcus aureus and related skin and soft tissue infections. The company's innovative approach aims to enhance treatment efficacy for patients with unmet medical needs.

Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Supply@ME is an independent fintech company based in London, United Kingdom, specializing in inventory monetization services for manufacturing and trading companies across Europe. The company offers a proprietary platform that allows businesses to convert their inventory into liquid assets, enhancing their financial flexibility. By providing innovative solutions, Supply@ME aims to support companies in optimizing their supply chains and improving cash flow management. Formerly a subsidiary of The AvantGarde Group, Supply@ME has established itself as a key player in the fintech sector, focusing on the unique needs of its clients in the manufacturing and trading industries.

IGEA Pharma N.V. is a health-tech and med-tech company based in Hoofddorp, the Netherlands, that focuses on developing and commercializing innovative products in the United States. The company offers Alz1, an at-home lab test kit designed to measure non-bound copper levels in the blood, alongside dietary supplements aimed at reducing heavy metal content in the body. Igea Pharma also manufactures dry aerosol generators for sanitizing air and surfaces, as well as devices for air sterilization and purification. With over 20 years of research dedicated to combating Alzheimer’s Disease and diabetes prevention, IGEA Pharma leverages its expertise to provide effective biomedical solutions and laboratory analysis services.